{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:28:06Z","timestamp":1790803686516,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T00:00:00Z","timestamp":1682208000000},"content-version":"vor","delay-in-days":112,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.rmcr.2023.101857","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T21:20:11Z","timestamp":1682371211000},"page":"101857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease triggered by COVID-19: What is the best practice for treatment?"],"prefix":"10.1016","volume":"43","author":[{"given":"Toshiyuki","family":"Yonezawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8087-1804","authenticated-orcid":false,"given":"Atsushi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Fukumitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Katano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Kako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Omote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmcr.2023.101857_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(22)00227-2","article-title":"Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study","author":"Figueroa-Parra","year":"2022","journal-title":"Lancet Rheumatol."},{"issue":"3","key":"10.1016\/j.rmcr.2023.101857_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmcr.2023.101857_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1002\/art.41596","article-title":"American College of Rheumatology guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic: version 3","volume":"73","author":"Mikuls","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.rmcr.2023.101857_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/resp.13682","article-title":"Acute exacerbations of fibrotic interstitial lung diseases","volume":"25","author":"Suzuki","year":"2020","journal-title":"Respirology"},{"key":"10.1016\/j.rmcr.2023.101857_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106898","article-title":"Clinical features of acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: comparison with idiopathic pulmonary fibrosis","volume":"200","author":"Otsuka","year":"2022","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmcr.2023.101857_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12931-022-01978-y","article-title":"Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model","volume":"23","author":"Hozumi","year":"2022","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.rmcr.2023.101857_bib7","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1093\/rheumatology\/keaa608","article-title":"Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: clinical features and prognosis","volume":"60","author":"Izuka","year":"2021","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.rmcr.2023.101857_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2169\/internalmedicine.8163-21","article-title":"Successful treatment with high-dose steroids for acute exacerbation of idiopathic pulmonary fibrosis triggered by COVID-19","volume":"61","author":"Omote","year":"2022","journal-title":"Intern. Med."},{"key":"10.1016\/j.rmcr.2023.101857_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.815924","article-title":"COVID-19-Triggered acute exacerbation of IPF, an underdiagnosed clinical entity with two-peaked respiratory failure: a case report and literature review","volume":"9","author":"Goto","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.rmcr.2023.101857_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.844609","article-title":"Acute exacerbation of rheumatoid arthritis misdiagnosed as COVID-19: a case report","volume":"9","author":"Torun","year":"2022","journal-title":"Front. Med."},{"issue":"19","key":"10.1016\/j.rmcr.2023.101857_bib11","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of covid-19 - final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.rmcr.2023.101857_bib12","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"GS-US-540-5774 investigators. Effect of remdesivir vs standard care on clinical status at 11 Days in patients with moderate COVID-19: a randomized clinical trial","volume":"324","author":"Spinner","year":"2020","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.rmcr.2023.101857_bib13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmcr.2023.101857_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in patients hospitalized with covid-19 pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.rmcr.2023.101857_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.29236","article-title":"Remdesivir in patients with severe kidney dysfunction: a secondary analysis of the catco randomized trial","volume":"5","author":"Cheng","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.rmcr.2023.101857_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01760-2019","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation","volume":"55","author":"Kreuter","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmcr.2023.101857_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00025-2022","article-title":"Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia, A double-blind, randomised, placebo-controlled trial","author":"Salvarani","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmcr.2023.101857_bib18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00296-016-3478-3","article-title":"Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study","volume":"36","author":"Akiyama","year":"2016","journal-title":"Rheumatol. Int."},{"issue":"9","key":"10.1016\/j.rmcr.2023.101857_bib19","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/imj.14670","article-title":"Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study","volume":"50","author":"Manfredi","year":"2020","journal-title":"Intern. Med. J."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007123000527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007123000527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:06:50Z","timestamp":1761959210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007123000527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":19,"alternative-id":["S2213007123000527"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2023.101857","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease triggered by COVID-19: What is the best practice for treatment?","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2023.101857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101857"}}